Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Insulin Resistance in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Alpelisib Pilot & Feasibility Study

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05733455
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:24.076987+00:00
Published At
2023-12-21T00:00:00+00:00
Record Updated At
2023-12-21
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Insulin Resistance", "Hyperinsulinemia", "Dyslipidemias"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-12-21"
protocolSection.identificationModule.nctId
"NCT05733455"
protocolSection.identificationModule.officialTitle
"Insulin Resistance in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Alpelisib Pilot \u0026 Feasibility Study"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Insulin Resistance (protocolSection.conditionsModule.conditions)
  • Hyperinsulinemia (protocolSection.conditionsModule.conditions)
  • Dyslipidemias (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.